What To Do After Trump Attempts to Fire Fed Governor Cook
The U.S. President is trying to fire Fed Governor Lisa Cook. Trump’s “with cause” is dependent on the claim that Cook, in her mortgage applications, described separate properties in Michigan and Georgia as primary residences.The U.S. Dollar index (DXY) traded steadily while treasury bond yields (IEF) (TLT) remained calm. The market’s lack of reaction suggests that her removal from the Fed will have no impact on monetary policy. In addition, markets did not react to Cook’s plans to sue to keep her job.If successful, the President may potentially have more influence on the Federal Reserve’s decision-making. Investors are worse off when the central bank’s policy decisions are not independent from politics.On the same day, the Trump Administration mulled over a partial government ownership in various U.S. defense contractors. This included Lockheed Martin (LMT), which makes fighter aircraft and munitions.The government’s investments in MP Materials (MP) and Intel (INTC) change the company’s priorities. Similarly, LMT stock may underperform as the government influences business decisions. Still, Lockheed depended on 73% of its 2024 sales from U.S. government contracts.Your TakeawayLockheed Martin stock trades closer to its 52-week low. Investors might consider Northrop Grumman (NOC), L3 Harris (LHX), and AeroVironment (AVAV) instead.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


